Skip to main content
. Author manuscript; available in PMC: 2018 Nov 9.
Published in final edited form as: JAMA Oncol. 2018 Jun 14;4(6):e173598. doi: 10.1001/jamaoncol.2017.3598

Figure 1. Association of Parity Laws with Monthly Out-of-Pocket Spending for Orally-Administered Anticancer Medications.

Figure 1.

Source: Authors analysis of Health Care Cost Institute Claims, 2008–2012. N=85,107 observations

Quantile regression analyses in propensity-weighted cohorts to predict changes in the distribution of patient out-of-pocket spending on a single fill of orally-administered anticancer therapy. Per fill medication costs were adjusted to reflect a standardized dose of therapy and inflation adjusted to 2012 dollars using the medical component of the consumer price index. Models were estimated using PROC QUANTREG in SAS 9.4. Values in parentheses represent baseline per-fill spending for each percentile.